Malaria: progress, perils, and prospects for eradication.

There are still approximately 500 million cases of malaria and 1 million deaths from malaria each year. Yet recently, malaria incidence has been dramatically reduced in some parts of Africa by increasing deployment of anti-mosquito measures and new artemisinin-containing treatments, prompting renewed calls for global eradication. However, treatment and mosquito control currently depend on too few compounds and thus are vulnerable to the emergence of compound-resistant parasites and mosquitoes. As discussed in this Review, new drugs, vaccines, and insecticides, as well as improved surveillance methods, are research priorities. Insights into parasite biology, human immunity, and vector behavior will guide efforts to translate parasite and mosquito genome sequences into novel interventions.

[1]  D. Conway,et al.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.

[2]  R. Snow,et al.  Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study , 2007, The Lancet.

[3]  L. Aravind,et al.  Plasmodium Biology Genomic Gleanings , 2003, Cell.

[4]  B. Sharp,et al.  Insecticide Resistance in Anopheles funestus (Diptera: Culicidae) from Mozambique , 2006 .

[5]  H. Yee,et al.  Intravital Observation of Plasmodium berghei Sporozoite Infection of the Liver , 2005, PLoS biology.

[6]  Andrea Crisanti,et al.  TRAP Is Necessary for Gliding Motility and Infectivity of Plasmodium Sporozoites , 1997, Cell.

[7]  Andrew P. Morse,et al.  Malaria early warnings based on seasonal climate forecasts from multi-model ensembles , 2006, Nature.

[8]  S. Kappe,et al.  Quantitative isolation and in vivo imaging of malaria parasite liver stages. , 2006, International journal for parasitology.

[9]  M. T. Marrelli,et al.  Transgenic malaria-resistant mosquitoes have a fitness advantage when feeding on Plasmodium-infected blood , 2007, Proceedings of the National Academy of Sciences.

[10]  Michael Lanzer,et al.  A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A , 2005, EMBO reports.

[11]  C. Wilson,et al.  Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. , 1995, Molecular and biochemical parasitology.

[12]  R. Snow,et al.  The burden of malaria mortality among African children in the year 2000. , 2006, International journal of epidemiology.

[13]  R. Tsuyuoka,et al.  Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. , 2006, The American journal of tropical medicine and hygiene.

[14]  L. Miller,et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.

[15]  M. Bangs,et al.  Status of malaria in Thailand. , 2000, The Southeast Asian journal of tropical medicine and public health.

[16]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[17]  R. Snow,et al.  Averting a malaria disaster , 1999, The Lancet.

[18]  B. Sharp,et al.  Effect of Artemether-Lumefantrine Policy and Improved Vector Control on Malaria Burden in KwaZulu–Natal, South Africa , 2005, PLoS medicine.

[19]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[20]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[21]  Marie-Claude Dubois,et al.  A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. , 2007, Vaccine.

[22]  Q. Bassat,et al.  Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial , 2007, The Lancet.

[23]  Anil K Ghosh,et al.  Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen , 2007, Proceedings of the National Academy of Sciences.

[24]  B. Sharp,et al.  Insecticide resistance in Anopheles funestus (Diptera: Culicidae) from Mozambique. , 2006, Journal of medical entomology.

[25]  P. Olliaro,et al.  In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. , 2006, Reproductive toxicology.

[26]  Usman Abdulmumini,et al.  A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods , 2006, Malaria Journal.

[27]  F. Pagés,et al.  Malaria Transmission and Insecticide Resistance of Anopheles gambiae (Diptera: Culicidae) in the French Military Camp of Port-Bouët, Abidjan (Côte d’Ivoire): Implications for Vector Control , 2006, Journal of medical entomology.

[28]  S. Kappe,et al.  Plasmodium sporozoite molecular cell biology. , 2004, Annual review of cell and developmental biology.

[29]  C. Klotz,et al.  Malaria circumsporozoite protein inhibits the respiratory burst in Kupffer cells , 2007, Cellular microbiology.

[30]  A. Devonshire,et al.  Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s. , 1998, Insect molecular biology.

[31]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Webster,et al.  Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. , 2005, The American journal of tropical medicine and hygiene.

[33]  T. Brewer,et al.  Acute high dose arteether toxicity in rats. , 1999, Neurotoxicology.

[34]  M. Deckert,et al.  Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. , 2007, The American journal of pathology.

[35]  S. Shorte,et al.  Quantitative imaging of Plasmodium transmission from mosquito to mammal , 2006, Nature Medicine.

[36]  Brian G. Williams,et al.  Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa , 2005, Emerging infectious diseases.

[37]  D. Kwiatkowski.  How malaria has affected the human genome and what human genetics can teach us about malaria. , 2005, American journal of human genetics.

[38]  Masao Yuda,et al.  Cell-Passage Activity Is Required for the Malarial Parasite to Cross the Liver Sinusoidal Cell Layer , 2004, PLoS biology.

[39]  L. Marrama,et al.  Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. , 2005, Microbes and infection.

[40]  F. Tripet,et al.  Longitudinal survey of knockdown resistance to pyrethroid (kdr) in Mali, West Africa, and evidence of its emergence in the Bamako form of Anopheles gambiae s.s. , 2007, The American journal of tropical medicine and hygiene.

[41]  Y. Chinzei,et al.  A Plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection † , 2004, Cellular microbiology.

[42]  E. Winzeler,et al.  Genomics, systems biology and drug development for infectious diseases. , 2007, Molecular bioSystems.

[43]  K. Maitland,et al.  Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. , 2003, QJM : monthly journal of the Association of Physicians.

[44]  T. Richie.  High road, low road? Choices and challenges on the pathway to a malaria vaccine , 2006, Parasitology.

[45]  J. Kublin,et al.  Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study , 2005, The Lancet.

[46]  S. Kappe,et al.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Catherine E. Costello,et al.  Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. , 2000 .

[48]  Vincent Corbel,et al.  Reduced Efficacy of Insecticide-treated Nets and Indoor Residual Spraying for Malaria Control in Pyrethroid Resistance Area, Benin , 2007, Emerging infectious diseases.

[49]  A. Oleinikov,et al.  Six Genes Are Preferentially Transcribed by the Circulating and Sequestered Forms of Plasmodium falciparum Parasites That Infect Pregnant Women , 2007, Infection and Immunity.

[50]  R. Carter.  Transmission blocking malaria vaccines. , 2001, Vaccine.

[51]  Jian Wang,et al.  The Genome Sequence of the Malaria Mosquito Anopheles gambiae , 2002, Science.

[52]  K. Kain,et al.  Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  W. Takken,et al.  Olfactory regulation of mosquito-host interactions. , 2004, Insect biochemistry and molecular biology.

[54]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[55]  P. Kremsner,et al.  Assessment of Volume Depletion in Children with Malaria , 2004, PLoS medicine.

[56]  S. Kappe,et al.  A clash to conquer: the malaria parasite liver infection , 2006, Molecular microbiology.

[57]  L. Zwiebel,et al.  Olfactory responses in a gustatory organ of the malaria vector mosquito Anopheles gambiae , 2006, Proceedings of the National Academy of Sciences.

[58]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[59]  R. Snow,et al.  The past, present and future of childhood malaria mortality in Africa. , 2001, Trends in parasitology.

[60]  B. Greenwood,et al.  Malaria in 2002 , 2002, Nature.

[61]  J. Zucker.  Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. , 1996, Emerging infectious diseases.

[62]  H. Noedl.  Artemisinin resistance: how can we find it? , 2005, Trends in parasitology.

[63]  David A. Fidock,et al.  Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.

[64]  Virander S. Chauhan,et al.  Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. , 2007, Vaccine.

[65]  B. Lowe,et al.  Bacteraemia complicating severe malaria in children. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[66]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[67]  Christl A. Donnelly,et al.  Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.

[68]  R. Sauerwein,et al.  Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. , 2007, The American journal of tropical medicine and hygiene.

[69]  J. Baird,et al.  Effectiveness of antimalarial drugs. , 2005, The New England journal of medicine.

[70]  S. Kappe,et al.  Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. , 2007, The Journal of infectious diseases.

[71]  R. Rosenberg,et al.  An estimation of the number of malaria sporozoites ejected by a feeding mosquito. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[72]  T. Wellems,et al.  Chloroquine-resistant malaria. , 2001, The Journal of infectious diseases.

[73]  D. Clyde,et al.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. , 1975, The American journal of tropical medicine and hygiene.

[74]  Q. Bassat,et al.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial , 2005, The Lancet.

[75]  R. Price,et al.  Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  C. Plowe,et al.  Mechanisms of Resistance of Malaria Parasites to Antifolates , 2005, Pharmacological Reviews.

[77]  Jake Baum,et al.  Invasion by P. falciparum Merozoites Suggests a Hierarchy of Molecular Interactions , 2005, PLoS pathogens.

[78]  J Mouchet,et al.  DDT house spraying and re-emerging malaria , 2000, The Lancet.

[79]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[80]  I. Sherman.  Molecular approaches to malaria , 2005 .

[81]  C. Klotz,et al.  Nomadic or sessile: can Kupffer cells function as portals for malaria sporozoites to the liver? , 2006, Cellular microbiology.

[82]  D. Fidock,et al.  Mechanisms of Antimalarial Drug Action and Resistance , 2005 .

[83]  M. Walther.  Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria , 2006, Expert review of vaccines.

[84]  S. Hay,et al.  The Malaria Atlas Project: Developing Global Maps of Malaria Risk , 2006, PLoS medicine.

[85]  N. Steers,et al.  The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites , 2005, European journal of immunology.

[86]  M. C. Thomson,et al.  Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme , 1995, The Lancet.

[87]  Lorian Schaeffer,et al.  A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila. , 2007, Science.

[88]  S. Hoffman,et al.  The Complexity of Protective Immunity Against Liver-Stage Malaria1 2 , 2000, The Journal of Immunology.

[89]  J. Vanderberg,et al.  Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.

[90]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[91]  D. Kwiatkowski,et al.  Prevalence and Boosting of Antibodies to Plasmodium falciparum Glycosylphosphatidylinositols and Evaluation of Their Association with Protection from Mild and Severe Clinical Malaria , 2002, Infection and Immunity.

[92]  Joe D. Cohen,et al.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.

[93]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[94]  Inacio Mandomando,et al.  Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.

[95]  F. T. Ter Kuile,et al.  Epidemiology and burden of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[96]  S. Kappe,et al.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine , 2005, Nature.

[97]  B. Gamain,et al.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.

[98]  J. Palensky,et al.  Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. , 2001, The Journal of infectious diseases.

[99]  Beatrice Gralton,et al.  Washington DC - USA , 2008 .

[100]  A. C. Alves,et al.  Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10 , 2006, Antimicrobial Agents and Chemotherapy.

[101]  Simon I Hay,et al.  Malaria epidemic early warning and detection in African highlands. , 2004, Trends in parasitology.

[102]  P. Seeberger,et al.  Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria , 2002, Nature.

[103]  Chris Drakeley,et al.  Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial , 2007, BMJ : British Medical Journal.

[104]  K. Reither,et al.  Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana , 2007, Antimicrobial Agents and Chemotherapy.

[105]  A. Burt,et al.  Homing endonuclease mediated gene targeting in Anopheles gambiae cells and embryos , 2007, Nucleic acids research.

[106]  M. Taylor,et al.  Bioassay and biochemical analyses of insecticide resistance in southern African Anopheles funestus (Diptera: Culicidae). , 2001, Bulletin of entomological research.

[107]  Rogerio Amino,et al.  Manipulation of Host Hepatocytes by the Malaria Parasite for Delivery into Liver Sinusoids , 2006, Science.

[108]  S. Kappe,et al.  Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. , 2007, The Journal of infectious diseases.

[109]  A. Hill.  Pre-erythrocytic malaria vaccines: towards greater efficacy , 2006, Nature Reviews Immunology.

[110]  P. Duffy.  Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia , 2007, Parasitology.

[111]  U. Frevert,et al.  Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. , 2004, International journal for parasitology.

[112]  Simon I Hay,et al.  Mapping the global extent of malaria in 2005. , 2006, Trends in parasitology.

[113]  M. Meissner,et al.  Molecular tools for analysis of gene function in parasitic microorganisms , 2007, Applied Microbiology and Biotechnology.

[114]  Susan Lewallen,et al.  Malarial retinopathy: a newly established diagnostic sign in severe malaria. , 2006, The American journal of tropical medicine and hygiene.

[115]  C. Janse,et al.  Plasmodium post-genomics: better the bug you know? , 2006, Nature Reviews Microbiology.

[116]  François Nosten,et al.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.

[117]  A. Moody.  Rapid Diagnostic Tests for Malaria Parasites , 2002, Clinical Microbiology Reviews.

[118]  R. Steketee,et al.  Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. , 2006, The Journal of infectious diseases.

[119]  P. Gerold,et al.  Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. , 1993, Annals of tropical medicine and parasitology.

[120]  I. Coppens,et al.  Plasmodium yoelii Sporozoites with Simultaneous Deletion of P52 and P36 Are Completely Attenuated and Confer Sterile Immunity against Infection , 2007, Infection and Immunity.

[121]  S. Kappe,et al.  L-FABP is a critical host factor for successful malaria liver stage development. , 2007, International journal for parasitology.

[122]  D. Conway,et al.  A large focus of naturally acquired Plasmodium knowlesi infections in human beings , 2004, The Lancet.

[123]  Abdullah S Ali,et al.  Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar , 2007, PLoS medicine.

[124]  M. Yazdanbakhsh,et al.  Co‐infection of helminths and malaria: modulation of the immune responses to malaria , 2006, Parasite immunology.

[125]  D. Fidock,et al.  Advances in understanding the genetic basis of antimalarial drug resistance. , 2007, Current opinion in microbiology.

[126]  M. Tanner,et al.  Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania , 2001, The Lancet.

[127]  R. Hunt,et al.  Anopheles funestus resistant to pyrethroid insecticides in South Africa , 2000, Medical and veterinary entomology.

[128]  J. Cox,et al.  Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. , 2005, JAMA.

[129]  M. Tanner,et al.  Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications , 2007, Malaria Journal.

[130]  Evgeny M. Zdobnov,et al.  Genome Sequence of Aedes aegypti, a Major Arbovirus Vector , 2007, Science.

[131]  S. Brooker,et al.  Malaria and helminth interactions in humans: an epidemiological viewpoint , 2006, Annals of tropical medicine and parasitology.

[132]  M. Molyneux,et al.  Nontyphoidal Salmonella infections of children in tropical Africa , 2000, The Pediatric infectious disease journal.

[133]  L. Chitsulo,et al.  The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. , 1994, The American journal of tropical medicine and hygiene.